Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein

Citation
A. Probst et al., Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein, ACT NEUROP, 99(5), 2000, pp. 469-481
Citations number
57
Categorie Soggetti
Neurosciences & Behavoir
Journal title
ACTA NEUROPATHOLOGICA
ISSN journal
00016322 → ACNP
Volume
99
Issue
5
Year of publication
2000
Pages
469 - 481
Database
ISI
SICI code
0001-6322(200005)99:5<469:AAAIMT>2.0.ZU;2-R
Abstract
Coding region and intronic mutations in the tau gene cause frontotemporal d ementia and parkinsonism linked to chromosome 17. Some of these mutations l ead to an overproduction of tau isoforms with four microtubule-binding repe ats. Here we have expressed the longest four-repeat human brain tau isoform in transgenic mice under the control of the murine Thy1 promoter. Transgen ic mice aged 3 weeks to 25 months overexpressed human tau protein in nerve cells of brain and spinal cord. Numerous abnormal, tau-immunoreactive nerve cell bodies and dendrites were seen. In addition, large numbers of patholo gically enlarged axons containing neurofilament- and tau-immunoreactive sph eroids were present, especially in spinal cord. Signs of Wallerian degenera tion and neurogenic muscle atrophy were observed. When motor function was t ested, transgenic mice showed signs of muscle weakness. Taken together, the se findings demonstrate that overexpression of human four-repeat tau leads to a central and peripheral axonopathy that results in nerve cell dysfuncti on and amyotrophy.